Cloned DNA from human papillomavirus (HPV) type 16 was subjected to restriction enzyme analysis. A genome size of 7.8 + 0.1 kb was determined and restriction maps were prepared. Fragments of HPV 16 DNA were nick-translated and hybridized with fragments of HPV 6b DNA. The two genomes appeared to be colinear. The physical state of HPV 16 DNA in genital tumours was analysed.
INTRODUCTION
The human papillomaviruses (HPV) are a remarkably heterogeneous group encompassing at least 30 distinct types. It has become evident that the DNA of certain types is closely associated with specific human cancers (for review, see . Among these are HPV 16 and HPV 18 which are present in a high percentage of cervical, vulval and penile cancer biopsies (Diirst et al., 1983; Boshart et al., 1984) . HPV 16 has also been demonstrated in a small percentage of flat condylomas of the cervix (Dfirst et al., 1983; H. Ikenberg, unpublished observation) . Follow-up studies of condylomata of the cervix revealed a progression to moderate dysplasia, carcinoma in situ and invasive cancer in 10~o of the patients (Meisels et al., 1982) . Precancerous lesions, such as Bowen's disease, also harbour HPV 16-specific sequences .
HPV 16 has been molecularly cloned directly from a cervical cancer biopsy and the distribution of this DNA in other genital tumours has been studied (Diirst et al., 1983) . In the present report the DNA of HPV 16 is further characterized and the physical state of the DNA in tumours is investigated.
METHODS
Biopsies and extraction of DNA. High molecular weight DNA was extracted from frozen (-70 °C) turnout biopsies (diagnosed by histopathological examination) by phenol/chloroform/isoamyl alcohol as described before (Gissmann et al., 1982) . Human lymphocytes were recovered from heparinized blood on a Ficoll gradient (Pharmacia) and the DNA extracted as cited above.
Restriction enzyme cleavage and blot hybridization. Restriction endonucleases were purchased from New England Biolabs or Bethesda Research Laboratories and used according to the manufacturer's recommendations. DNA was electrophoresed in 0.4 to 1-2~ agarose gels using 40 mM-Tris-acetate, 2 mM-EDTA, pH 7-8 as the running buffer. DNA was transferred onto nitrocellulose filters (Schleicher & Schfill) according to the Southern (1975) 0000-6531 © 1985 SGM method. The prehybridization solution contained : 5 x SSC (0.75 M-NaC1, 0.075 M-sodium citrate), 50 mM-sodium phosphate buffer, pH 6.5, 0.02~ polyvinylpyrrolidone, 0.02~ bovine serum albumin, 0.02~ Ficol1400, 0-5 mg/ml denatured tRNA (brewer's yeast) and the formamide concentration as given below. Filters were prehybridized at 42 °C overnight.
Hybridization was performed at 42 °C for 2 to 4 days in a similar solution but containing 20 mM-sodium phosphate buffer pH 6-5 and 0.1 mg/ml tRNA, and the labelled DNA. For hybridization under stringent conditions (Tin -18 °C) 50~ formamide was used and for non-stringent conditions (Tin -40 °C) 20~ formamide was used. Filters were washed three times, each for 30 min, in 0.3 M-NaCI, 0.03 M-sodium citrate, 0.1 ~ SDS at 48 °C (non-stringent) or 68 °C (stringent) and autoradiographed at -70 °C.
Labelling ofDNA. Nick translation (Rigby et al., 1977) to a specific activity of 108 c.p.m./vtg has been described previously (Fresen et al., 1979) ; l06 c.p.m./ml hybridization solutions were used in most hybridization experiments.
CsCl/ethidium bromide gradient centriJugation. This technique allows differentiation between supercoiled and nicked-circular or linear DNA (Radloffet al., 1967) . Tumour DNA (100 ~tg) was added to 11 ml 1 x TE (10 miTris, 1 mM-EDTA, pH 8.0) containing CsCI at a density of 1.6 g/ml and 200 ~tg/ml ethidium bromide. The solution was carefully mixed and centrifuged at 145000g at 20 °C for 60 h. The gradient was collected in fractions of 500 ~tl each. Ethidium bromide was extracted from every fraction using n-butanol. After dialysis against l x TE, the DNA was further analysed.
Two-dimensionalgelelectrophoresis. Linear and circular DNA could be differentiated using two-dimensional gel electrophoresis (Johnson & Grossmann, 1977; Wettstein & Stevens, 1982) . To ensure good electrophoretic separation the tumour DNA was first digested with a restriction enzyme not cleaving within the viral genome. Agarose gels of 0.4~ and 0.7~ were used for the first and second dimension respectively.
Cloning ofvirus/celljunction]mgments. Virus/cell junction fragments were cloned from a genomic library of a cervical carcinoma (WV 2965), constructed in bacteriophage lambda L47 after cleavage with BamHI. The cloning procedure, screening of recombinants and propagation of phages have been described before (Gissmann et al., 1982) .
RESULTS
Cloned HPV 16 DNA was used to allocate the cleavage sites of various restriction endonucleases (Fig. 1) . The molecular weights of the fragments were determined using agarose gel electrophoresis. The molecular size of the genome was estimated to be 7-8 + 0-1 kb.
Using purified 32p-labelled fragments of HPV 16 DNA for hybridization to cleaved HPV 6b DNA under conditions of low stringency, colinearity of the two genomes could be established (Fig. 2) suggesting that HPV 16 has a similar genomic organization to HPV 6b and the other papillomaviruses (Chen et al., 1982; Danos et al., 1982; Schwarz et al., 1983) .
CsC1/ethidium bromide gradient centrifugation of six benign genital tumour DNAs positive for HPV 16 (two condylomata acuminata, two Bowenoid papuloses and two mild dysplasias) showed that the viral DNA existed exclusively as 8 kb circles. The results of one condyloma acuminatum is shown in Fig. 3 . By the same technique, it could be shown that approximately 50~ of the viral DNA in the cervical carcinoma DNA from which HPV 16 DNA had been cloned (D(irst el al., 1983) existed in the form of oligomeric episomes of varying size (Fig. 4) . There is evidence for a head-to-tail genome arrangement of high molecular weight episomal HPV 16 DNA since after cleaving with BamHI (a single cut enzyme for HPV 16) most of the DNA banding at a density of 1.59 g/ml was converted to molecules co-migrating with linear HPV 16 DNA (see marker in Fig. 4 ). Moreover, digesting the tumour DNA with a multi-cut enzyme (e.g. PstI, data not shown) followed by Southern blot hybridization resulted in the same cleavage pattern as determined for the cloned HPV 16 DNA (Fig. 1) . A substantial part of HPV 16 DNA in this tumour co-migrated with cellular DNA by gradient centrifugation and twodimensional gel electrophoresis (data not shown) suggesting a covalent linkage to the host DNA. A similar situation (20~ of the DNA as oligomeric episomes, 80~o co-migration with cellular DNA) was observed in the biopsy from a patient with Bowen's disease. This is considered as a clearly pre-cancerous lesion of the penis or vulva (Knox & Joseph, 1976) .
The physical state of HPV 16 DNA in two other cervical carcinomas appeared to be different. In two biopsies (WV 2965, WV 855) there was no evidence for episomal HPV DNA after centrifugation of tumour DNA in a CsCl/ethidium bromide gradient or by two-dimensional gel electrophoresis (Fig. 5) . Digestion of carcinoma DNA (WV 2965) with restriction enzymes whereas the other arrows point to oligomers of increasing size. Some of the viral DNA co-migrated with high molecular weight cellular DNA (see fraclion with a density of 1.56 g/ml).
cutting several times within the HPV 16 genome and subsequent Southern blot analysis resulted in the typical fragment pattern known for the cloned HPV 16 DNA, with a slight modification in the AvaII fragment pattern (Fig. 6 ). In addition, at least six bands representing approximately one copy/cell (see marker DNA in Fig. 6 ) were detected, some of which revealed a shift after combined digestion with enzymes not cutting within the HPV 16 genome. Cleavage of the same tumour DNA with BamHI followed by hybridization resulted in a main band of about 8 kb in size (data not shown). Therefore, it is assumed that HPV 16 DNA is integrated at different sites in the host genome mainly in the form of head-to-tail repeats and that the submolar bands may represent virus/cell junctions (Fig. 7) . To prove this hypothesis three junction fragments were cloned using the strategy outlined in Fig. 8 . After construction of a genomic library by inserting BamHI-digested turnout DNA into lambda L47 as vector the recombinants were screened by hybridization with 32p-labelled HPV 16 DNA. Since the HPV 16 DNA was calculated to be present in 50 to 100 copies/cell the majority of positive plaques should contain the complete HPV 16 genome (Fig. 7) . Thus, only those bacteriophage clones which proved to be negative when hybridized in parallel with a genomic fragment of the HPV 16 DNA were further processed (see Fig. 8 ). Three of the recombinants that have been identified by this approach were further characterized. They contain inserts of 8.0 kb (clone 1.2 A), 8.6 kb (clone 3.2 A) and 9.0 kb (clone 4.1 A) respectively (Fig. 9) . By cleaving with different restriction enzymes followed by Southern blot hybridization with 32p-labelled HPV 16 DNA it was shown that only parts of the cloned D N A fragments contain HPV 16-specific sequences. Positive hybridization with some fragments of digested clone 1.2 A and 4.1 A DNA using nick-translated DNA extracted from primary human embryo lung fibroblasts (HEL) as probe (Fig. 9) indicated the presence of repetitive cellular DNA.
The 3-4 kb HindlII fragment of clone 3.2 A (see arrow in Fig. 9 ) was shown to be negative when annealed with HPV 16 or with HEL DNA and therefore probably consists of unique cellular DNA. This fragment was subcloned in pBR322 and used as a probe for hybridizing tumour DNA (WV 2965) as well as lymphocyte D N A of the same patient (Fig. 10) . In the case of (Fig. 6) . A junction fragment seen as submolar band in Fig. 6 was shifted after multiple cleavage with PstI and HPV 16 non-cut enzymes (HindllI, XbaI, Bgll) . The identification of the same 8.6 kb fragment using 32p-labelled H P V 16 D N A , as expected if clone 3.2 A has not been constructed as a cloning artefact, was not possible since the virus/cell junction fragment was hidden by the large n u m b e r of 8 kb H P V 16 molecules generated by BamHI cleavage of the tumour D N A . The third band (6.6 kb) after BamHI cleavage of the tumour D N A is probably due to r e a r r a n g e m e n t of the genome within this locus. A f t e r HindlII cleavage, a 3.4 kb fragment can be seen for both D N A s as well as some additional bands in the tumour D N A , giving further support for r e a r r a n g e m e n t in this locus. Different restriction enzyme fragments of cloned HPV 16 DNA were positive by hybridization with 32p-labelled clones 1.2 A, 3.2 A or 4.1 A DNA respectively, indicating that within the viral DNA there exists no specific region for integration into the genome of this particular tumour (data not shown).
DISCUSSION
The DNA of HPV 16 exhibits the characteristic features observed for other HPV types. Its genome shows the size typical for HPV DNA and it has been found as 8 kb circular molecules in benign genital lesions. Furthermore, the genome organization corresponds to that of other papillomaviruses as indicated by colinear alignment of restriction enzyme fragments crosshybridizing with HPV 6b DNA under conditions of low stringency (Fig. 2) . This similarity was further confirmed when HPV 6b and HPV 16 were compared on the basis of their nucleotide sequences (K. Seedorf & W. R6wekamp, personal communication). As far as the physical state of viral DNA in malignant tumours is concerned, HPV 16 seems to differ from other papillomaviruses tested thus far. The DNA of different HPV types, of bovine papillomaviruses as well as of the cottontail rabbit papillomavirus (CRPV) apparently persist in an episomal state within the tumours although there is evidence for integration of CRPV DNA in some carcinomas (McVay et al., 1982; Sugawara et al., 1983; Georges et al., 1984) . The DNA of HPV 18 which thus far has been found exclusively in malignant genital tumours also appears to be integrated within the host genome (Boshart et al., 1984) . HPV 16 DNA, however, persists as 8 kb circular molecules in non-malignant genital lesions like condylomata acuminata, mild dysplasias and Bowenoid papuloses. In one carcinoma in situ of the penis (Bowen's disease) and in one invasively growing cervical carcinoma, 8 kb circles either were not found or could be detected only after very long exposure of the Southern blot (see arrow at mol. wt. marker 4.4 in Fig. 4 ). These tumours contained the HPV 16 DNA as multimeric circles and associated with cellular DNA as shown by CsC1/ethidium bromide gradient centrifugation and by twodimensional gel electrophoresis. By using the same techniques the HPV 16-specific D N A of two invasively growing cervical carcinomas was shown to occur only as high molecular weight linear DNA. Although it cannot be ruled out completely that this high molecular weight linear HPV 16 DNA has been generated from oligomeric circles during the extraction procedure, integration seems to be the most likely interpretation.
Direct evidence for a fusion between viral and cellular sequences is provided for one cervical carcinoma where different virus/cell junction fragments could be cloned. Similar clones were obtained from an HPV 16-positive lung carcinoma (J. Y. Le, personal communication) and from three different cervical carcinoma cell lines harbouring HPV 18 DNA .
It is an open question whether integration of HPV 16 and HPV 18 D N A into the cell genome is a causative event for malignant transformation or a consequence of general DNA rearrangement occurring in the tumour cell. The original hypothesis that HPV 16 represents a defective virus capable of episomal replication only in the presence of a helper virus (Dfirst et at., 1983) now seems unlikely since HPV 16 DNA was detected in four of the six benign genital lesions as extrachromosomal molecules without any indication of another HPV type within these biopsies. That integration might be involved in maintaining the transformed state is suggested by the stable arrangement of HPV 18 DNA within the HeLa cell line over many passages (Boshart et al., 1984) and by the evidence for HPV 18-specific transcripts running into the adjacent cellular DNA .
Experiments are now in progress to clarify the question of whether integration of HPV DNA in malignant genital tumours occurs in certain chromosomal loci or randomly throughout the human genome. We wish to thank Dr H. zur Hausen for helpful discussion and Drs P. Spradbrow and M. Pawlita for critical reading of this manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (SFB 31: Tumorentstehung und -Entwicklung).
